SeedtoB is an investment company focused on healthcare AI startups. Founded by former Jvion leaders, SeedtoB invests in Seed and Series A companies developing AI applications for healthcare. The company aims to support founders in reaching Series B funding.

SeedtoB

At seedToB Capital, we know what it's like to start a company. There are easier ways to make a living and the odds are against you. Yet you dismiss the odds, take huge risks, and defer the niceties. When you meet us, you’ll hear a common theme throughout our conversations - a love for innovation that improves healthcare and a deep respect for entrepreneurs. We've founded startups and we know for you this is much more than a job - it's your life's work.

We believe that using advanced AI to drive efficiency in healthcare is no longer a choice. However, most clinical applications of AI - including many backed by huge investments - have failed or produced limited results that aren't scalable beyond controlled pilots or early adaptor settings.

As entrepreneurs, we saw the Healthcare Artificial Intelligence market segment evolve from the beginning, and we have successfully built and exited businesses that positively impacted millions of lives.

Our mission is to give early stage entrepreneurs access to the experience we developed while navigating the various stages of these emerging market segments. We're investors with an entrepreneurial mindset, focused on helping you and your team chart the most efficient path to the Series B stage.

SeedtoB Capital

Congratulations to Shimmer co-founder Christal Wang on being recognized by Inc. Magazine for her work in the ADHD and neurodiversity space!

Great to see Feel Therapeutics in MedCity News, highlighting the need for objective data and measurement in mental health - and how AI can play a role in changing how we track patients' emotional state. Check out the article below:

Delighted to share our co-lead investment in Shimmer's AI-powered ADHD coaching platform! Shimmer is designed to deliver personalized and evidence-backed coaching to the large (and growing) global neurodiverse community. Congrats to Christal Wang and Vikram Sreedhar! 

Learn more about the platform at TechCrunch:

A great way to kick off 2024 at Feel Therapeutics - excited for the year ahead with new advisors and partners on board!

Delighted to share that our portfolio company OncoLens has been included on the Inc 5000 list this year. Well-deserved recognition for the team as they continue to build out a best-in-class multidisciplinary care platform for cancer care.

Our team is thrilled to share we recently led an investment in Canid, the end-to-end vaccine management platform empowering pediatric practices to streamline vaccine operations and deliver better care for the next generation. We're excited to support Pedro Sanchez de Lozada and team as they expand their offering into 10 new states across the U.S. Learn more about Canid's technology below. #healthcare #pediatrics #vaccinemanagement

Metric
Company Name	SeedtoB
Symbol
MSH ID	COM:SEEDTOB
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	US
Stage
Employee Count	5
Website	seedtob.com
LinkedIn	seedtob
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SEED

COM:SEEDTOB

SeedtoB

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue